Waregem (Belgium) / Rotterdam (The Netherlands) [1], 27 January 2010 – The special shareholders’ meeting held by Arseus NV today approved all motions put forward by the Board of Directors. The minutes of the special shareholders’ meeting are available on the Arseus corporate website at www.Arseus.com.
For more information please contact:
Constantijn van Rietschoten
Investor Relations Manager
+31 88 33 11 222 (office)
+31 6 536 91 585 (mobile)
constantijn.van.rietschoten@arseus.com
Profile Arseus
Arseus is a multinational group of companies that supplies products, services and concepts to professionals and institutions in the European healthcare sector. Arseus is subdivided into four divisions and operates in the markets for pharmaceutical compounding for pharmacies, dental products, medical and surgical products, and medical IT-solutions. In 2009 Arseus realised turnover of approximately €391 million with 1,600 employees in 16 European countries. The Belgian company Arseus NV is located in Waregem, and is listed on Euronext Brussels and Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.
In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.
[1] This press release was sent out by Arseus NV and Arseus BV.